Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Gleeson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Seminars in Nephrology|March 13, 2025
The Role of Mucosal Immunity: What Can We Learn From Animal and Human Studies?Patrick J Gleeson, Renato C Monteiro
Microorganisms|April 23, 2022
Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?Renato C Monteiro, Dina Rafeh, Patrick J Gleeson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 7, 2023
IgA nephropathy in adults-treatment standardPatrick J Gleeson, Michelle M O'Shaughnessy, Jonathan Barratt
Clinical Kidney Journal|January 23, 2016
What should the characteristics and attributes of an accredited nephrology training programme be? Looking for high standardsPatrick J Gleeson, Itzchak Slotki, Jorge B Cannata-Andia, et al.
Malaria Journal|March 3, 2019
Acute interstitial nephritis with podocyte foot-process effacement complicating Plasmodium falciparum infectionPatrick J Gleeson, John A O'Regan, Teresa McHale, et al.
Pediatric Nephrology (Berlin, Germany)|February 11, 2020
New therapeutic perspectives for IgA nephropathy in childrenAlexandra Cambier, Patrick J Gleeson, Héloise Flament, et al.
Immunological Reviews|November 23, 2024
Immunoglobulin A Antibodies: From Protection to Harmful RolesPatrick J Gleeson, Niels O S Camara, Pierre Launay, et al.
Molecular Immunology|October 3, 2021
Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapiesMarie-Bénédicte Le Stang, Patrick J Gleeson, Mohamed R Daha, et al.
Shock (Augusta, Ga.)|November 24, 2016
Angiotensin II in Refractory Septic ShockElio Antonucci, Patrick J Gleeson, Filippo Annoni, et al.
Pediatric Nephrology (Berlin, Germany)|January 8, 2022
Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive caseAlexandra Cambier, Claire Dossier, Julien Hogan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Seminars in Nephrology|March 13, 2025
The Role of Mucosal Immunity: What Can We Learn From Animal and Human Studies?Patrick J Gleeson, Renato C Monteiro
Microorganisms|April 23, 2022
Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?Renato C Monteiro, Dina Rafeh, Patrick J Gleeson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 7, 2023
IgA nephropathy in adults-treatment standardPatrick J Gleeson, Michelle M O'Shaughnessy, Jonathan Barratt
Clinical Kidney Journal|January 23, 2016
What should the characteristics and attributes of an accredited nephrology training programme be? Looking for high standardsPatrick J Gleeson, Itzchak Slotki, Jorge B Cannata-Andia, et al.
Malaria Journal|March 3, 2019
Acute interstitial nephritis with podocyte foot-process effacement complicating Plasmodium falciparum infectionPatrick J Gleeson, John A O'Regan, Teresa McHale, et al.
Pediatric Nephrology (Berlin, Germany)|February 11, 2020
New therapeutic perspectives for IgA nephropathy in childrenAlexandra Cambier, Patrick J Gleeson, Héloise Flament, et al.
Immunological Reviews|November 23, 2024
Immunoglobulin A Antibodies: From Protection to Harmful RolesPatrick J Gleeson, Niels O S Camara, Pierre Launay, et al.
Molecular Immunology|October 3, 2021
Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapiesMarie-Bénédicte Le Stang, Patrick J Gleeson, Mohamed R Daha, et al.
Shock (Augusta, Ga.)|November 24, 2016
Angiotensin II in Refractory Septic ShockElio Antonucci, Patrick J Gleeson, Filippo Annoni, et al.
Pediatric Nephrology (Berlin, Germany)|January 8, 2022
Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive caseAlexandra Cambier, Claire Dossier, Julien Hogan, et al.
Pageof 2